Asia · Regional markets · The Financial Express

Regulator tightens monitoring cancer drug prices

Published by The Financial Express · India 8 h ago

Detailed summary

The NPPA urges strict monitoring of revised prices for 137 anti-cancer drugs to ensure hospitals, pharmacies, and distributors comply, aiming to prevent overcharging and ensure…

Read the full article on The Financial Express Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.financialexpress.com)

Also worth reading

CNBC-TV18

FIIs pour in ₹7,831 crore, extend November buying spree as markets rally

Business Standard

SIP openings hit 18-month low in October, closures rise to 18-month high

Mint

HAL shares edge lower after Q2 results despite 16% YoY profit growth; why did investors turn cautious? Decoded

The Business Times

South-east Asia is about to lose Nvidia’s best salesman

The Straits Times Business

New business-class seats, Air India plans among key takeaways from SIA’s first-half results briefing

Tech in Asia